Synaptic Systems offers many antibodies which have been successfully used in retina and vision research. We have added new polyclonal antibodies against Brn3a (#411 003) to our portfolio. Brn3a, also referred to as POU4F1, RGC-1 or Oct-T1, is a transcription factor highly expressed in the developing peripheral sensory nervous system, cells of the B- and T-lymphocytic lineages and in certain regions of the CNS. In the retina, Brn3a is a well-established marker for retinal ganglion cells. These new antibodies function exceptionally well in IHC applications, even at high dilutions.
Figure 1: Brn3a cat. no. 411 003 IHC
Indirect immunostaining of PFA fixed paraffin mouse retina section with rabbit anti-Brn3a (cat. no. 411 003, dilution 1:5000; green). Nuclei have been visualized by DAPI staining (blue).
Courtesy: Dr. Hanna Regus-Leydig, Institute of Animal Physiology, Dept. of Biology, University of Erlangen-Nürnberg
Figure 2: Brn3a cat. no. 411 003 IHC
Indirect immunostaining of PFA fixed flatmount mouse retina with rabbit-anti Brn3a (cat. no. 400 003, dilution 1:500; red). Nuclei have been visualized by DAPI staining (blue).
Courtesy: Prof. Udo Bartsch, Dept. of Ophthalmogy, University Medical Center Hamburg Eppendorf (UKE)
Cat. No. | Product Description | Application | Quantity | Price | Cart |
---|
411 003 | Brn3a, rabbit, polyclonal, affinity purifiedaffinity | IHC IHC-P | 50 µg | $380.00 | |
411 004 | Brn3a, Guinea pig, polyclonal, antiserumantiserum | IHC IHC-P | 100 µl | $365.00 | |
411 017 | Brn3a, rat, monoclonal, purified IgG IgG | IHC IHC-P | 100 µg | $415.00 |